Company Insight – Page 7 – media

Connected Health Platform Hopes to Enhance Manner in Which Patients Take Medication

Phillips-Medisize introduced a connected health platform to enhance the way people take medication while using connected health devices.
- Source: DigitalHealthAge
- 746
- August 2, 2018
Company Insight digital health medical device Phillips
Nebraska Informs Pfizer to Prosecute Over Lethal Injection

Pfizer objected to the use of its drugs for lethal injection procedures last year by asking states to return the drugs immediately for a refund. But not all of them have halted its utilization. Hence, with an execution planned in Nebraska dated Aug. 14, a state senator is urging Pfizer to prosecute if the drug usage is not halted.
- Source: FiercePharma
- 980
- August 1, 2018
Company Insight Pfizer pharmaceutical
GlaxoSmithKline will Shut Bangladesh Drug Manufacturing Operations by End 2018

GlaxoSmithKline will be closing its drug manufacturing operations in Bangladesh by the end of this year and will remain only with its healthcare business that produces Sensodyne, Horlicks and Glaxose-D.
- Source: Reuters
- 644
- July 31, 2018
Company Insight GSK Pharma Asia
Bayer Sidelines Essure Concerns as Anecdotal, Legal Claims Build Up

A week post Bayer’s announcement on the withdrawal of Essure, its contraceptive implant from the market by this year-end due to inadequate sales, its clinical safety is questioned as consumer and legal stress builds up concerning complaints of extreme fatigue, pain and bleeding.
- Source: FierceBiotech
- 533
- July 30, 2018
Bayer Company Insight contraceptive device Essure
Novartis Extends Donation of Egaten® (triclabendazole) Until 2022

Novartis has renewed its memorandum of understanding with the World Health Organization (WHO) to lengthen its drug donation for Egaten® (triclabendazole) to 2022 and continues its war against liver fluke. WHO lists Egaten as the only medicine for fascioliasis and also includes it in the Model List of Essential Medicines.
- Source: World Pharma News
- 961
- July 30, 2018
Company Insight Novartis WHO
GlaxoSmithKline Invests $300 Million in 23andMe

23andMe declared an investment of $300 million on Wednesday, made by GlaxoSmithKline to attain special access to their DNA database.
- Source: HealthcareIT News
- 597
- July 27, 2018
Company Insight genetic testing GSK
Biomedical Blockchain Research Center Opens at Mount Sinai

The opening of a new Biomedical Blockchain Research Center was announced by the Icahn School of Medicine at Mount Sinai and the Institute for Next Generation Healthcare which aims to solve healthcare and medical science issues with new technologies and data.
- Source: Healthcare IT News
- 811
- July 26, 2018
AI blockchain Company Insight EHR
Novartis Neuroendocrine Tumor App Featured in iStore

In a recent launch, Novartis’ Galaxies of Hope neuroendocrine tumor app received an additional bump from Apple. The “Featured App” status in the first week itself helped in receiving positive reviews and downloads for the community-building app.
- Source: FiercePharma
- 801
- July 25, 2018
Company Insight mHealth Novartis
Bayer Announces the end of Essure Sales in the US

Bayer announced on last Friday that it would stop the sales of its Essure birth control system in the United States by the end of this year due to a steady decline in its sales making the product no longer justifiable. Bayer insisted that its decision to discontinue Essure sales is only for business reasons and not for any safety or efficacy concerns.
- Source: MDDI Online
- 652
- July 25, 2018
Company Insight contraceptive device FDA
1.5 Million Singapore Patient Records, Including the Prime Minister’s, Stolen by Hackers

An organized cyberattack on the Singapore government’s health database caused a leak of 1.5 million patients’ records, including Prime Minister Lee Hsien Loong, for nearly an entire week.
- Source: HealthcareIT News
- 790
- July 25, 2018
Company Insight cybersecurity digital health Singapore

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.